Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Olatuton
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olatuton 20mg inj vials
0803043N0BCABAG
|
Olatuton | Octreotide acetate | Malignant Disease and Immunosuppression | 4 |
|
Olatuton 30mg inj vials
0803043N0BCACAF
|
Olatuton | Octreotide acetate | Malignant Disease and Immunosuppression | 4 |
|
Olatuton 10mg inj vials
0803043N0BCAAAE
|
Olatuton | Octreotide acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.